FDA Adverse Event Injury Summary report: N

EXT. DRAINAGE SYSTEM III WITHOUT VENT CATH

MDR report key: 4130094 · Received September 30, 2014

Report

Report Number
1226348-2014-12014
Event Type
Injury
Date Received
September 30, 2014
Date of Event
September 9, 2014
Manufacturer
CODMAN & SHURTLEFF
Product Code
JXG
PMA / PMN Number
PK954021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

IT HAS BEEN COMMUNICATED THAT THE DEVICE AND/OR LOT INFORMATION IS NOT AVAILABLE FOR EVALUATION. WITHOUT THE DEVICE AND/OR LOT INFORMATION, IT IS NOT POSSIBLE FOR CODMAN TO CONDUCT A PROPER INVESTIGATION. IF AT SOME POINT THE DEVICE AND/OR LOT INFORMATION DOES BECOME AVAILABLE, THIS COMPLAINT WILL BE RE-OPENED, EVALUATED AND A FOLLOW UP REPORT WILL BE FILED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME, THIS COMPLAINT IS CONSIDERED CLOSED. COMPLAINT SAMPLE DISCARDED BY CUSTOMER

Description of Event or Problem · 1

THE CASING AT THE CSF PORT WAS CRACKED, SO A CSF LEAK WAS DISCOVERED UPON FLUSHING THE BLOCKED DRAIN. THE BUNG AT THE CSF PORT WAS REMOVABLE. PATIENT OUTCOME NOT KNOWN. NO REPORTED ADVERSE EVENT TO PATIENT. ON (B)(6) 2014, ADDITIONAL QUESTIONS ASKED TO CUSTOMER: WHAT DOES ¿THE BUNG AT THE CSF PORT WAS REMOVABLE¿ MEAN? THE NEEDLELESS CSF SAMPLE PORT WAS REMOVABLE (BY TWISTING WITH NORMAL PRESSURE) FROM THE HARD PLASTIC JOINT CASING WHERE THE WORD CSF IS WRITTEN (WHICH IS, RIGHT BY THE WORD CSF ON THE JOINT, ALSO THE LOCATION WHERE THE LEAK WAS IDENTIFIED). WHAT ACTIONS WERE TAKEN BY THE SURGEON? AS THE SYSTEM WAS BLOCKED AND NOT ABLE TO BE FLUSHED OPEN DURING USE, THE DECISION WAS MADE TO REPLACE IT WITH AN IDENTICAL UNIT. WAS THE SYSTEM REPLACED? YES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
608225 EXT. DRAINAGE SYSTEM III WITHOUT VENT CATH SHUNT, CENTRAL NERVOUS SYSTEM & COMPS JXG CODMAN & SHURTLEFF UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention